Clinical Trials Browser

Phase 2/3 × Neoplasms × Darbepoetin alfa × Clear all

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

Phase 2/3 Terminated

Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness